Search

everythinglearnresearchcommunity

for

Search:↓

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

A 19-year-old male had two rare skin conditions causing scarring and permanent hair loss.

People with Collagen VI-related myopathies may often have hair loss and scalp issues.

Skin biopsies are recommended for confirming alopecia diagnosis due to variability in clinical assessments; the link between vitamin D levels and alopecia is unclear.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

The document explains various skin conditions and their treatments.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Female pattern hair loss is common, worsens with age, and requires long-term treatment to manage.

Trichoscopy is an effective, noninvasive method for early diagnosis of Female Pattern Hair Loss.

A woman had an allergic skin reaction to a hair loss treatment containing minoxidil and should not use it.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

New understanding and treatments for hair loss are improving, but more research is needed.

Using camphorated and mentholated chlorophenol in dental treatments can lead to severe gastrointestinal issues and hair and nail loss.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Some diets and supplements might help with skin disorders, but their effectiveness varies and more research is needed.

Female pattern hair loss treatments vary in effectiveness and may have side effects.